TGFB1 and cancer: Accumulation of NRF2 in cancer cells may activate expression of inhibitory cytokines and ligands directly by transcriptional regulation or by activating inflammation pathways such as interferon pathways, TGFβ pathway, TNFα pathway, and complement pathway.